Navigation Links
Court Certifies Overtime Class Action Against Forest Labs, According to The Ottinger Firm, P.C.
Date:6/7/2011

NEW YORK, June 7, 2011 /PRNewswire/ -- A class action alleging Forest Labs (NYSE: FRX) pharmaceutical sales representatives were unlawfully denied overtime pay has been certified by a New York federal court, The Ottinger Firm, P.C., announced today.

U.S. District Judge William H. Pauley, of the Southern District of New York, granted the plaintiffs' motion for conditional collective action certification under the federal Fair Labor Standards Act (FLSA).

The national "opt-in" class includes Forest Labs sales representatives who were employed by the company in the three years before the case was filed in August 2010. The Ottinger Firm is proposed counsel for members of the class.

The case is "Elmaria Martinez, et al., v. Forest Laboratories, Inc., et al.," Civil Action No. 10 cv 6032 (WHP) in the U.S. District Court, Southern District of New York.

The defendants are New York-based Forest Laboratories, Inc. and subsidiary Forest Pharmaceuticals, Inc. The named plaintiff, Ms. Martinez, was employed by the defendants between 2002 and 2011.

Attorney Robert W. Ottinger said, "This is a notable victory for Ms. Martinez and the Forest Labs pharmaceutical sales representatives covered by this class action. We believe the strength of this case and recent appellate court rulings confirm the overtime eligibility for these pharmaceutical sales representatives under the FLSA. We are pleased the Court conditionally certified this class action and look forward to moving forward with the case."

The Court determined that Ms. Martinez and the putative class were similarly situated in light of their common classification as exempt from overtime under the FLSA, because they shared common job descriptions and because they were subject to common employment policies, Mr. Ottinger said.

Attorney Contacts: Robert W. Ottinger and Christopher Q. Davis, The Ottinger Firm, P.C., New York, 212.571.2000, www.ottingerlaw.com.


'/>"/>
SOURCE The Ottinger Firm, P.C.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Comments on Court Ruling in Amylin Litigation
2. Federal Court Asked to Compel Decision in Marijuana Scheduling Action
3. 83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court
4. U.S. District Court Order Maintains Patent Exclusivity for Lillys Cymbalta
5. McDonald Hopkins Law Firm Alert: Recent Court of Appeals Decision Highlights the Need to Properly Define the Role of Sales Representatives
6. Verathon Inc. GlideScope Video Laryngoscope Patent Upheld in Court
7. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
8. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
9. Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
10. Watson Announces Favorable District Court Ruling in Generic Fentora® Patent Suit
11. Court Rules on First Set of Patents in FENTORA Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... , Jan. 13, 2017  Alfalfa, cattle, leafy greens and ... environmental sampling film , which emphasizes the food industry,s shift ... highlights how COPAN,s Swab Rinse Kit ... the surface sampling process in the wake of the new ... COPAN is expanding the U.S. production ...
(Date:1/13/2017)... 2017 The 2016 election resulted in ... states voting in favor of legalizing cannabis for recreational use, ... in the U.S. In addition, the state of ... cannabis products sales. The ArcView Group has published an updated ... cannabis sales in the U.S. last year reached $6.7 billion, a ...
(Date:1/13/2017)... 2017 Research and Markets has announced the ... report to their offering. ... Cystic fibrosis (CF) is a progressive genetic condition ... fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective ... and result in the buildup of a thick and sticky mucus ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... ... first-quality education and high-level training standards to an international multidisciplinary group of healthcare ... problems. As a way to further its mission at the grassroots level, iaedp ...
(Date:1/15/2017)... NY (PRWEB) , ... January 15, 2017 , ... In ... accounts in the United States for the asthma & allergy friendly mark. This certification ... to independently test and identify consumer products to be more suitable for the 60+ ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco Magazine recently ... Area counties for 2017. Almost 1,000 nominations were submitted and a little over ... Results were announced the magazine’s January 2017 issue . , Under the ...
(Date:1/14/2017)... ... 2017 , ... According to a December 9 article ... the risk of type 2 diabetes, Alzheimer’s, and cardiovascular disease. Southern California based ... linked to a Mediterranean diet are only some of the many reasons that ...
(Date:1/13/2017)... ... , ... A January 10 article in the Daily Star on ... with an emphasis on some new techniques that the publication says are becoming more ... casually to his patients and colleagues as Dr. J, comments that the best plastic ...
Breaking Medicine News(10 mins):